• English
  • Français
Bladder Cancer CanadaBladder Cancer CanadaBladder Cancer CanadaBladder Cancer Canada
  • Bladder Cancer
    • See Red?
    • What is Bladder Cancer?
    • Statistics and Risk Factors
    • Symptoms and Diagnosis
    • Staging and Grading
    • Types of Bladder Cancer
      • Non-Muscle Invasive Bladder Cancer
      • Muscle Invasive Bladder Cancer
      • Metastatic Bladder Cancer
      • Upper Tract Urothelial Carcinoma
    • Treatment Options
      • TURBT
      • BCG
      • Chemotherapy and Radiation
      • Bladder Removal Surgery
      • Immunotherapy
      • Bladder Preservation Options
      • Palliative Care
      • Clinical Trials
      • Advanced Bladder Cancer Treatment
    • Research and Studies
  • Patients
    • Get Support
      • Support Groups
      • One2One Peer Support
      • Online Discussion Forum
      • Contact Us by Phone or Email
    • Navigating Your Diagnosis
      • Newly Diagnosed?
      • Coping With Emotions
      • Health and Wellness Resources
      • Clinical Trials
    • Educational Resources
      • Guidebooks
      • Webinars and Videos
      • Podcast
      • Newsletter
      • Glossary
    • Upcoming Events
    • News and Stories
    • Links and Other Resources
  • Get Involved
    • Donate
    • Fundraise
    • Volunteer
    • Share Your Story
    • Patient Study Recruitment
    • Patient Self-Advocacy
    • Bladder Cancer Awareness Month
    • Your Impact
  • Health Care Practitioners
    • Doctor Resources
    • BCC Research Grant Applications
    • BCC Research Grant Recipients
    • CBCIS
    • CBCRN
    • Medical Advisory Board
  • About Us
    • Who We Are
    • Board of Directors
    • Staff
    • Medical Advisory Board
    • Sponsors and Partners
    • Financial Statements and Annual Reports
    • Newsletter
    • Contact Us
  • Walk With Us
  • Donate

BCG (OncoTICE) Supply Update – August 8, 2019

    Home Latest news and stories BCG (OncoTICE) Supply Update – August 8, 2019
    NextPrevious

    BCG (OncoTICE) Supply Update – August 8, 2019

    By Bladder Cancer Canada | Latest news and stories | 5 June, 2019 | 0

    IMPORTANT UPDATE – AUGUST 8, 2019

    Bladder Cancer Canada and its Medical Advisory Board were advised by Merck Canada back in November 2018 that they would be experiencing limited supply of Bacillus Calmette-Guerin (BCG) in the coming year.

    As the only supplier of BCG in Canada Merck established an allocation plan last fall and committed to keeping information updated at: https://www.drugshortagescanada.ca/drug/4066

    During that time Merck expected to fulfill between 75% and 100% of the normal demand with an anticipated end date of October 2019.

    Effective August 7, 2019 BCC has been advised by Merck that the new anticipated end date for the allocation plan has been extended to December 2020.

    Below is an approach for consideration for physicians to address the shortage/outage of Bacillus Calmette-Guérin (BCG):

    Download the document here: Approach to Address BCG Shortage updated June 2019

    The Medical Advisory Board of Bladder Cancer Canada and the CUA Guidelines Committee have reviewed and support these suggestions.

    Bladder Cancer Canada is awaiting final discussions between Health Canada and a second supplier with regards to accessing the BCG Russian strain for use in Canada. Bladder Cancer Canada is continuing to work closely with Health Canada and do everything possible to expedite the approval of a second BCG supplier in Canada and minimize the effect of the shortage on bladder cancer patients.   

    Read the Bladder Cancer Canada Position Statement on the BCG Shortage

    Bladder Cancer Canada will continue to update you as we receive more information.

    No tags.

    Related Post

    • Volunteer’s personal approach leads to deeper commitment from corporate supporter

      By Bladder Cancer Canada | 0 comment

      By: Tom Eremondi Read time: 3.5 minutes Admittedly old school, Gerry Ross’ approach to dealing with a local walk sponsor nurtured and enhanced the relationship to a surprising level. This story, however, dates back aboutRead more

    • “The risk of recurrence of my cancer is high, so I need to take care of myself.”

      By Bladder Cancer Canada | 0 comment

      Read time: 2 minutes We were so pleased to see one of our new Peer Support Volunteers, Gervais  Fournier, featured in this New Normal, Same Cancer news story, seen last month in the Le JournalRead more

    • This May, we’re making bladder cancer impossible to ignore! 

      By Bladder Cancer Canada | Comments are Closed

      Subscribe today! Our May newsletter is filled with lots of initiatives to create awareness for bladder cancer including blogs, podcasts, helpful facts, webinars and more. Bladder cancer is the 5th most common cancer in Canada andRead more

    • Bladder cancer & COVID-19 FAQ

      By Bladder Cancer Canada | Comments are Closed

      Uncertain times are upon us, around the world, as we globally respond to the coronavirus (COVID-19) that is affecting us all on some level. Many members of our bladder cancer community are directing questions our way aboutRead more

    • Protecting Yourself During the Coronavirus Outbreak

      By Bladder Cancer Canada | Comments are Closed

      (The following content is sourced from various sites advising on the coronavirus. For more information, please see the end of this article for additional resources. Photo Credit: CDC) As news of the coronavirus (COVID-19) continues toRead more

    • Health Canada Approves BALVERSA

      By Bladder Cancer Canada | Comments are Closed

      In a recent press release, Janssen Pharmaceutical Companies of Johnson & Johnson have announced that they have received approval from Health Canada for BALVERSA™ (erdafitinib), the first FGFR Kinase inhibitor for the treatment of patientsRead more

    • Patient Story: Ann

      By Bladder Cancer Canada | Comments are Closed

      I was diagnosed with bladder cancer after a significant amount of blood appeared in my urine.

    • Announcing the Launch of Our New Hematuria Brochure: A Vital Resource for Early Bladder Cancer Detection 

      By Bladder Cancer Canada | Comments are Closed

      We have developed this easy-to-understand resource aimed at increasing awareness of hematuria.

    • Our First Annual Research Report Is Live! 

      By Bladder Cancer Canada | Comments are Closed

      Our first Annual Research Report brings you exciting updates from the world of bladder cancer research.

    • Tax Season is Upon Us! 

      By Bladder Cancer Canada | Comments are Closed

      Spring has sprung and so has tax season! Don’t miss out on valuable credits or deductions! 

    • Happy National Volunteer Week 2025!

      By Bladder Cancer Canada | Comments are Closed

      National Volunteer Week is celebrated annually to honour all the volunteers who make a powerful impact.

    NextPrevious

    Recent Blog Posts

    • Patient Story: Ann
    • Announcing the Launch of Our New Hematuria Brochure: A Vital Resource for Early Bladder Cancer Detection 
    • Our First Annual Research Report Is Live! 
    • Economic Impacts of a Cancer Diagnosis on Canadians
    • Tax Season is Upon Us! 

    Upcoming Events

    • Outreach Events
    • In-person Education Events
    • Support Groups
    • Webinars

    Blog Categories

    • Blog
    • Honouring our volunteers
    • Latest news and stories
    • Patient Stories
    • Upcoming meeting and events
    • Volunteers
    • Webinar

    Bladder Cancer Canada

    4936 Yonge Street, Suite 1000, Toronto, ON M2N 6S3
    Phone: 1-866-674-8889
    Email & Media Contact: info@bladdercancercanada.org

    Privacy Policy | Donor Bill of Rights

    Charitable Reg No. 83612 6060 RR0001

    © Bladder Cancer Canada.

    SUBSCRIBE TO OUR NEWSLETTER
    SEND US A MESSAGE
    • Bladder Cancer
      • See Red?
      • What is Bladder Cancer?
      • Statistics and Risk Factors
      • Symptoms and Diagnosis
      • Staging and Grading
      • Types of Bladder Cancer
        • Non-Muscle Invasive Bladder Cancer
        • Muscle Invasive Bladder Cancer
        • Metastatic Bladder Cancer
        • Upper Tract Urothelial Carcinoma
      • Treatment Options
        • TURBT
        • BCG
        • Chemotherapy and Radiation
        • Bladder Removal Surgery
        • Immunotherapy
        • Bladder Preservation Options
        • Palliative Care
        • Clinical Trials
        • Advanced Bladder Cancer Treatment
      • Research and Studies
    • Patients
      • Get Support
        • Support Groups
        • One2One Peer Support
        • Online Discussion Forum
        • Contact Us by Phone or Email
      • Navigating Your Diagnosis
        • Newly Diagnosed?
        • Coping With Emotions
        • Health and Wellness Resources
        • Clinical Trials
      • Educational Resources
        • Guidebooks
        • Webinars and Videos
        • Podcast
        • Newsletter
        • Glossary
      • Upcoming Events
      • News and Stories
      • Links and Other Resources
    • Get Involved
      • Donate
      • Fundraise
      • Volunteer
      • Share Your Story
      • Patient Study Recruitment
      • Patient Self-Advocacy
      • Bladder Cancer Awareness Month
      • Your Impact
    • Health Care Practitioners
      • Doctor Resources
      • BCC Research Grant Applications
      • BCC Research Grant Recipients
      • CBCIS
      • CBCRN
      • Medical Advisory Board
    • About Us
      • Who We Are
      • Board of Directors
      • Staff
      • Medical Advisory Board
      • Sponsors and Partners
      • Financial Statements and Annual Reports
      • Newsletter
      • Contact Us
    • Walk With Us
    • Donate
    Bladder Cancer Canada